ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in ESSA Pharma Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- −9 vs. Q3 2022
- Shares held
- 33.4M
- −425.4K (−1.3%) vs. Q3 2022
- Total value
- $84.1M
- +$21.9M (+35.3%) vs. Q3 2022
- New holders
- 8
- 9 more added
- Sold out
- 17
- 17 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 32 | $4.30M |
| Q2 2025 | 36 | $52.7M |
| Q1 2025 | 36 | $50.1M |
| Q4 2024 | 45 | $58.8M |
| Q3 2024 | 32 | $212.7M |
| Q2 2024 | 31 | $185.1M |
| Q1 2024 | 33 | $297.5M |
| Q4 2023 | 31 | $229.4M |
| Q3 2023 | 36 | $103.4M |
| Q2 2023 | 39 | $89.8M |
| Q1 2023 | 37 | $98.3M |
| Q4 2022 | 45 | $84.1M |
| Q3 2022 | 54 | $62.2M |
| Q2 2022 | 59 | $119.0M |
| Q1 2022 | 70 | $229.9M |
| Q4 2021 | 60 | $530.1M |
| Q3 2021 | 75 | $297.4M |
| Q2 2021 | 80 | $976.0M |
| Q1 2021 | 70 | $895.7M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding ESSA Pharma Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 113 | $0 | 0.00% | −16,647−99.3% | Reduced |
| Simplex Trading, LLC | 241 | $0 | 0.00% | −109−31.1% | Reduced |
| Newbridge Financial Services Group, Inc. | 31 | $78 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 50 | $126 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 109 | $275 | 0.00% | +109 | New |
| Crewe Advisors LLC | 265 | $668 | 0.00% | 00.0% | Unchanged |
| Laurel Wealth Advisors LLC | 600 | $1.51K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 900 | $2.28K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,014 | $2.56K | 0.00% | +1,006+12,575.0% | Added |
| BNP Paribas Arbitrage, SA | 1,500 | $3.78K | 0.00% | +1,500 | New |
| Quantbot Technologies LP | 1,751 | $4.41K | 0.00% | −400−18.6% | Reduced |
| Royal Bank of Canada | 1,765 | $5.00K | 0.00% | −4,000−69.4% | Reduced |
| Advisor Group Holdings, Inc. | 5,225 | $13.0K | 0.00% | +1,000+23.7% | Added |
| UBS Group AG | 6,522 | $16.4K | 0.00% | +6,522 | New |
| Bessemer Group Inc | 6,852 | $17.0K | 0.00% | 00.0% | Unchanged |
| One Wealth Advisors, LLC | 8,333 | $21.0K | 0.00% | +8,333 | New |
| JPMorgan Chase & Co | 8,751 | $22.0K | 0.00% | −64,917−88.1% | Reduced |
| Northern Trust Corp | 11,728 | $29.6K | 0.00% | −140−1.2% | Reduced |
| Geode Capital Management, LLC | 19,039 | $47.0K | 0.00% | 00.0% | Unchanged |
| Hunting Hill Global Capital, LLC | 20,000 | $50.4K | 0.03% | +10,000+100.0% | Added |
| Walleye Capital LLC | 20,784 | $52.4K | 0.00% | −216,369−91.2% | Reduced |
| State Street Corp | 24,961 | $62.9K | 0.00% | +110+0.4% | Added |
| Jump Financial, LLC | 27,500 | $69.3K | 0.00% | +27,500 | New |
| Kapitalo Investimentos Ltda | 33,400 | $84.2K | 0.07% | +33,400 | New |
| Cubist Systematic Strategies, LLC | 34,086 | $85.9K | 0.00% | −21,528−38.7% | Reduced |
| Renaissance Technologies LLC | 34,624 | $87.0K | 0.00% | −151,286−81.4% | Reduced |
| Thrivent Financial for Lutherans | 33,389 | $87.0K | 0.00% | +2,052+6.5% | Added |
| Two Sigma Investments, LP | 91,203 | $229.8K | 0.00% | −256,555−73.8% | Reduced |
| CIBC World Markets Inc. | 165,641 | $417.0K | 0.00% | +88,405+114.5% | Added |
| Two Sigma Advisers, LP | 172,100 | $433.7K | 0.00% | −170,300−49.7% | Reduced |
| Millennium Management LLC | 174,475 | $440.0K | 0.00% | −232,286−57.1% | Reduced |
| D. E. Shaw & Co., Inc. | 250,385 | $631.0K | 0.00% | −249,448−49.9% | Reduced |
| Driehaus Capital Management LLC | 264,571 | $666.7K | 0.01% | +264,571 | New |
| OrbiMed Advisors LLC | 365,300 | $920.6K | 0.02% | −275,345−43.0% | Reduced |
| Rhenman & Partners Asset Management AB | 375,000 | $945.0K | 0.10% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 524,944 | $1.32M | 0.03% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 605,141 | $1.52M | 0.09% | −87,769−12.7% | Reduced |
| Ally Bridge Group (NY) LLC | 811,555 | $2.05M | 1.99% | +811,555 | New |
| Adage Capital Partners GP, L.L.C. | 1,042,531 | $2.63M | 0.01% | 00.0% | Unchanged |
| Avidity Partners Management LP | 1,855,400 | $4.68M | 0.11% | −604,600−24.6% | Reduced |
| Morgan Stanley | 2,006,477 | $5.06M | 0.00% | −99,542−4.7% | Reduced |
| PFM Health Sciences, LP | 3,844,332 | $9.69M | 0.41% | +2,366,080+160.1% | Added |
| Soleus Capital Management, L.P. | 3,869,392 | $9.75M | 1.40% | +1,228,853+46.5% | Added |
| Bellevue Group AG | 7,898,583 | $19.9M | 0.26% | +2,000,000+33.9% | Added |
| BVF Inc | 8,748,629 | $22.0M | 0.93% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −1,561,251−100.0% | Sold out |
| RTW Investments, LP | 0 | $0 | 0.00% | −1,311,294−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −417,532−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −405,700−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −382,282−100.0% | Sold out |
| Omega Fund Management, LLC | 0 | $0 | 0.00% | −328,196−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −115,122−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −72,046−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −44,832−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −40,619−100.0% | Sold out |
| AlpInvest Partners B.V. | 0 | $0 | 0.00% | −39,930−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −24,531−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −24,052−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −23,338−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −19,872−100.0% | Sold out |
| Alta Wealth Advisors LLC | 0 | $0 | 0.00% | −11,285−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −3,300−100.0% | Sold out |